Furthermore, the upregulation of VEGF mediated by the activation of JAK2/STAT3 signaling pathway has been demonstrated in non-small-cell lung cancer (Zhao et al., 2011) and other tumor cells, indicating that a similar correlation may also exist in mtLE subpopulation. This evidence concerns the gene JAK2 and non-small cell lung carcinoma.